IL10 and neoplasm: In a recent study, we have shown that intratumoral injection of the caerin 1.1/1.9 mixture significantly prolonged the survival time of TC-1 tumour-bearing mice that were immunised with an HPV16 E7 peptide-based vaccine along with IL-10 and PD-1 blockade (23).